SK14662003A3 - Použitie polyklonálnych imunoglobulínov - Google Patents
Použitie polyklonálnych imunoglobulínov Download PDFInfo
- Publication number
- SK14662003A3 SK14662003A3 SK1466-2003A SK14662003A SK14662003A3 SK 14662003 A3 SK14662003 A3 SK 14662003A3 SK 14662003 A SK14662003 A SK 14662003A SK 14662003 A3 SK14662003 A3 SK 14662003A3
- Authority
- SK
- Slovakia
- Prior art keywords
- antibodies
- immunization
- immunoglobulin
- vaccine
- polyclonal
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
- A61K39/39558—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against tumor tissues, cells, antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Communicable Diseases (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Biomedical Technology (AREA)
- Virology (AREA)
- Pulmonology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AT0086001A AT410637B (de) | 2001-06-01 | 2001-06-01 | Verwendung von polyklonalen immunglobulinen |
| PCT/AT2002/000088 WO2002096455A2 (de) | 2001-06-01 | 2002-03-19 | Verwendung von polyklonalen immunglobulinen als impfstoff |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SK14662003A3 true SK14662003A3 (sk) | 2004-05-04 |
Family
ID=3682339
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SK1466-2003A SK14662003A3 (sk) | 2001-06-01 | 2002-03-19 | Použitie polyklonálnych imunoglobulínov |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US20040151717A1 (de) |
| EP (1) | EP1399185A2 (de) |
| JP (1) | JP2004532261A (de) |
| CN (1) | CN1512895A (de) |
| AT (1) | AT410637B (de) |
| AU (1) | AU2002242447B2 (de) |
| BR (1) | BR0210239A (de) |
| CA (1) | CA2449026A1 (de) |
| CZ (1) | CZ20033273A3 (de) |
| HU (1) | HUP0400031A3 (de) |
| IL (2) | IL158950A0 (de) |
| MX (1) | MXPA03010829A (de) |
| NO (1) | NO20035282D0 (de) |
| PL (1) | PL367835A1 (de) |
| SK (1) | SK14662003A3 (de) |
| WO (1) | WO2002096455A2 (de) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10127712A1 (de) * | 2001-06-07 | 2002-12-19 | Torsten Witte | Anwendung von IgM-Antikörpern gegen dsDNA beim systemischen Lupus erythematodes mit Nephritis |
| WO2005023867A1 (en) * | 2003-09-08 | 2005-03-17 | Medical Research Council | Method for the treatment or prophylaxis of tuberculosis |
| CN106999588A (zh) * | 2014-12-03 | 2017-08-01 | 瑞士杰特贝林生物制品有限公司 | 具有增加的稳定性的包含免疫球蛋白的药物产品 |
| FR3072880A1 (fr) * | 2017-10-30 | 2019-05-03 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Formulation liposomale et son utilisation en therapie anti-tumorale |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3340487A1 (de) * | 1983-11-09 | 1985-05-15 | Sandoz-Patent-GmbH, 7850 Lörrach | Neue therapeutische verwendung |
| EP0438803B1 (de) * | 1990-01-26 | 1997-03-12 | Immunomedics, Inc. | Impfstoffe gegen Krebs und Infektionskrankheiten |
| JP2795289B2 (ja) * | 1990-09-04 | 1998-09-10 | 富士通株式会社 | 電子機器におけるプリント板ユニットの保持構造 |
| US5219578A (en) * | 1991-02-25 | 1993-06-15 | Innovet, Inc. | Composition and method for immunostimulation in mammals |
| WO1992015885A1 (en) * | 1991-03-11 | 1992-09-17 | Idec Pharmaceuticals Corporation | Methods for selecting antibody reagents; anti-idiotype antibodies; and aids vaccine formulations |
| US5562902A (en) * | 1994-03-14 | 1996-10-08 | Arp Biomed, Inc. | Immunotherapeutic method of treating cancerous diseases by administration of intravenous immunoglobulin |
| TWI248819B (en) * | 1999-09-27 | 2006-02-11 | Arp Biomed Ltd | Pharmaceutical composition containing IVIG for use in treating lymphoma |
| AT409086B (de) * | 1999-11-16 | 2002-05-27 | Igeneon Krebs Immuntherapie | Neue verwendung von antikörpern als impfstoffe |
| WO2001096392A2 (en) * | 2000-06-15 | 2001-12-20 | Millennium Pharmaceuticals, Inc. | 22109, a novel human thioredoxin family member and uses thereof |
| AT410636B (de) * | 2001-03-23 | 2003-06-25 | Igeneon Krebs Immuntherapie | Verfahren zur herstellung eines impfstoffes |
-
2001
- 2001-06-01 AT AT0086001A patent/AT410637B/de not_active IP Right Cessation
-
2002
- 2002-03-19 US US10/478,942 patent/US20040151717A1/en not_active Abandoned
- 2002-03-19 BR BR0210239-0A patent/BR0210239A/pt not_active Application Discontinuation
- 2002-03-19 EP EP02707990A patent/EP1399185A2/de not_active Withdrawn
- 2002-03-19 JP JP2002592964A patent/JP2004532261A/ja active Pending
- 2002-03-19 CA CA002449026A patent/CA2449026A1/en not_active Abandoned
- 2002-03-19 IL IL15895002A patent/IL158950A0/xx active IP Right Grant
- 2002-03-19 HU HU0400031A patent/HUP0400031A3/hu unknown
- 2002-03-19 SK SK1466-2003A patent/SK14662003A3/sk not_active Application Discontinuation
- 2002-03-19 CZ CZ20033273A patent/CZ20033273A3/cs unknown
- 2002-03-19 WO PCT/AT2002/000088 patent/WO2002096455A2/de active Application Filing
- 2002-03-19 CN CNA028111214A patent/CN1512895A/zh active Pending
- 2002-03-19 PL PL02367835A patent/PL367835A1/xx not_active Application Discontinuation
- 2002-03-19 MX MXPA03010829A patent/MXPA03010829A/es unknown
- 2002-03-19 AU AU2002242447A patent/AU2002242447B2/en not_active Ceased
-
2003
- 2003-11-19 IL IL158950A patent/IL158950A/en not_active IP Right Cessation
- 2003-11-27 NO NO20035282A patent/NO20035282D0/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| MXPA03010829A (es) | 2004-02-17 |
| AT410637B (de) | 2003-06-25 |
| PL367835A1 (en) | 2005-03-07 |
| IL158950A (en) | 2008-04-13 |
| EP1399185A2 (de) | 2004-03-24 |
| HUP0400031A2 (hu) | 2004-04-28 |
| JP2004532261A (ja) | 2004-10-21 |
| WO2002096455A3 (de) | 2003-12-24 |
| AU2002242447B2 (en) | 2007-11-08 |
| HUP0400031A3 (en) | 2006-03-28 |
| US20040151717A1 (en) | 2004-08-05 |
| NO20035282L (no) | 2003-11-27 |
| CN1512895A (zh) | 2004-07-14 |
| NO20035282D0 (no) | 2003-11-27 |
| CA2449026A1 (en) | 2002-12-05 |
| ATA8602001A (de) | 2002-11-15 |
| WO2002096455A2 (de) | 2002-12-05 |
| CZ20033273A3 (en) | 2004-07-14 |
| BR0210239A (pt) | 2004-03-30 |
| IL158950A0 (en) | 2004-05-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US8444974B2 (en) | Use of antibodies for the vaccination against cancer | |
| Díaz et al. | Immune responses in breast cancer patients immunized with an anti-idiotype antibody mimicking NeuGc-containing gangliosides | |
| JPH08511015A (ja) | 治療用抗体断片 | |
| Ferguson et al. | Immunoregulatory properties of antigenic fragments from bovine serum albumin | |
| AU780853B2 (en) | Use of anti-idiotypical antibodies as vaccines against cancer | |
| EP2838919A1 (de) | An den übergang zwischen ch4- und c-epsilon-mx-domänen bindende anti-mige-antikörper | |
| Roehnisch et al. | Chemically linked phage idiotype vaccination in the murine B cell lymphoma 1 model | |
| Manheimer et al. | Anti-immunoglobulin antibodies. V. Age-dependent variation of clones stimulated by polysaccharide TI-2 antigens in 129 and MRL mice spontaneously producing anti-gamma-globulin antibodies. | |
| SK14662003A3 (sk) | Použitie polyklonálnych imunoglobulínov | |
| SK11732003A3 (sk) | Spôsob výroby očkovacej látky | |
| US20060018901A1 (en) | Use of antibodies in a very low dose for the vaccination against cancer | |
| EP0211368B1 (de) | Monoklonaler Antiasialo-GM1-Antikörper | |
| Rombach et al. | Induction of an anti-Fab, anti-DNA and anti-RNA polymerase I autoantibody response network in rabbits immunized with SLE anti-DNA antibody. | |
| US20040265318A1 (en) | Use of antibodies for the vaccination against cancer | |
| Haba et al. | Mechanisms of induction of tolerance to syngeneic IgE | |
| CZ20032573A3 (cs) | Způsob výroby očkovací látky | |
| JPH06508829A (ja) | サプレッサーｔ細胞ハイブリドーマ | |
| WO2001066141A1 (fr) | Agents therapeutiques et prophylactiques diriges contre le syndrome des antiphospholipides |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC9A | Refused patent application |